DOLASETRON: 18 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
18
Total FAERS Reports
0
Deaths Reported
4
Hospitalizations
18
As Primary/Secondary Suspect
Dec 11, 2001
FDA Approved
Discontinued
Status
Active Ingredient: DOLASETRON MESYLATE · FDA Application: 020623 ·
First Report: 20140109 · Latest Report: 20250821
What Are the Most Common DOLASETRON Side Effects?
#1 Most Reported
Drug hypersensitivity
5 reports (27.8%)
#2 Most Reported
Nausea
3 reports (16.7%)
#3 Most Reported
White blood cell count decreased
2 reports (11.1%)
All DOLASETRON Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 5 | 27.8% | 0 | 0 |
Who Reports DOLASETRON Side Effects? Age & Gender Data
Gender: 92.9% female, 7.1% male. Average age: 46.1 years. Most reports from: US. View detailed demographics →
Is DOLASETRON Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 0 |
| 2024 | 3 | 0 | 2 |
| 2025 | 2 | 0 | 1 |
Official FDA Label for DOLASETRON
Official prescribing information from the FDA-approved drug label.